Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CXSL2200240	四价流感病毒裂解疫苗（MDCK细胞）	influenza vaccine(split virion),inactivated,quadrivalent	Injection	Biological Products(2.2)	New Drug Application	2022-06-03		view
CXSL2200542	四价流感病毒裂解疫苗（MDCK细胞）	influenza vaccine(split virion),inactivated,quadrivalent	Injection	Biological Products(2.2)	New Drug Application	2022-10-25	Shanghai Institute of Biological Products Co Ltd	view
CXSL2300149	四价流感病毒裂解疫苗（MDCK细胞）	influenza vaccine(split virion),inactivated,quadrivalent	Injection	Biological Products(2.2)	New Drug Application	2023-02-23	Beijing Institute of Biological Products Co Ltd	view
CXSL2300148	四价流感病毒裂解疫苗（MDCK细胞）	influenza vaccine(split virion),inactivated,quadrivalent	Injection	Biological Products(2.2)	New Drug Application	2023-02-23	Beijing Institute of Biological Products Co Ltd	view
CXSL2300207	四价流感病毒裂解疫苗（MDCK细胞）	influenza vaccine(split virion),inactivated,quadrivalent	Injection	Biological Products(2.2)	New Drug Application	2023-03-23		view
CXSL2400138	四价流感病毒裂解疫苗（MDCK细胞）	influenza vaccine(split virion),inactivated,quadrivalent	Injection	Biological Products(2.2)	New Drug Application	2024-02-21		view
CXSL2400449	四价流感病毒裂解疫苗（MDCK细胞）	influenza vaccine(split virion),inactivated,quadrivalent	Injection	Biological Products(2.2)	New Drug Application	2024-07-15		view
CXSL2400629	四价流感病毒裂解疫苗（MDCK细胞）	influenza vaccine(split virion),inactivated,quadrivalent	Injection	Biological Products(2.2)	New Drug Application	2024-09-19		view